Proteomic and lipidomic biomarkers in the diagnosis and progression of inflammatory bowel disease – a review

Purpose There is an increasing prevalence of inflammatory bowel disease (IBD) and to date, no effective treatment has been developed and the exact etiology of this disease remains unknown. Nevertheless, a growing number of proteomic and lipidomic studies have identified certain proteins and lipids w...

Ausführliche Beschreibung